U.S. Sexually Transmitted Disease Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Kits), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus, and Others), By Setting (Laboratory Testing and Point-of-Care) By End User (Hospital & Clinics, Clinical Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108002

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Incidence of Key Diseases, 2022
2. Key Industry Developments: Mergers, Acquisitions & Partnerships
3. New Product Launches, By Key Players
4. Overview of Regulatory Scenario in the U.S.
5. Technological Advancements in Sexually Transmitted Disease Testing Market
6. Impact of COVID-19 on Global Sexually Transmitted Disease Testing Market
U.S. Sexually Transmitted Disease Testing Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Kits
2. Market Analysis, Insights and Forecast – By Application
  1. Chlamydia
  2. Syphilis
  3. Genital Herpes
  4. Gonorrhea
  5. Human Immunodeficiency Virus
  6. Human Papillomavirus (HPV)
  7. Others
3. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of Care (POC)
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals and Clinics
  2. Diagnostic Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2022)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Abbott
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. BD
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Hologic, Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. bioMerieux, Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Cepheid (Danaher Corporation)
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Bio-Rad Laboratories, Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. DiaSorin S.p.A
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Incidence of Key Diseases, 2022
2. Key Industry Developments: Mergers, Acquisitions & Partnerships
3. New Product Launches, By Key Players
4. Overview of Regulatory Scenario in the U.S.
5. Technological Advancements in Sexually Transmitted Disease Testing Market
6. Impact of COVID-19 on Global Sexually Transmitted Disease Testing Market
U.S. Sexually Transmitted Disease Testing Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Kits
2. Market Analysis, Insights and Forecast – By Application
  1. Chlamydia
  2. Syphilis
  3. Genital Herpes
  4. Gonorrhea
  5. Human Immunodeficiency Virus
  6. Human Papillomavirus (HPV)
  7. Others
3. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of Care (POC)
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals and Clinics
  2. Diagnostic Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2022)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Abbott
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. BD
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Hologic, Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. bioMerieux, Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Cepheid (Danaher Corporation)
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Bio-Rad Laboratories, Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. DiaSorin S.p.A
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: U.S. Sexually Transmitted Disease Testing Market Revenue Breakdown (USD billion, %), By Product Type, 2022 & 2030

Figure 2: U.S. Sexually Transmitted Disease Testing Market Value Share (%), By Product Type, 2022 & 2030

Figure 3: U.S. Sexually Transmitted Disease Testing Market Value Share (%), By Application, 2022 & 2030

Figure 4: U.S. Sexually Transmitted Disease Testing Market Value Share (%), By Setting, 2022 & 2030

Figure 5: U.S. Sexually Transmitted Disease Testing Market Value Share (%), By End User, 2022 & 2030

Figure 6: U.S. Sexually Transmitted Disease Testing Market Share (%), 2022

List of Tables

Table 1: U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 2: U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 3: U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 4: U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

STUDY PERIOD: 2019-2030
BASE YEAR: 2022
HISTORICAL DATA: 2019-2021
NO OF PAGES: 80

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com